Extended Data Fig. 1: Sequencing pipeline and overlapping peptide selection.
From: Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial
a, Schematic depicting DNA sequencing of tumor and normal tissue or peripheral blood, RNA sequencing from tumor tissue, and HLA typing to vaccine peptide selection. Created in Biorender. Galsky, M. (2025) https://BioRender.com/r06n376. b, Schema of overlapping peptide pools correspond to a vaccine synthetic long peptide used for stimulating PBMCs.
